Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Virbac SA (VIRP) Stock Price & Analysis

11 Followers

VIRP Stock Chart & Stats

€358.00€0.50(0.14%)
At close: 5:30 PM GMT+1
€300€325€350Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 352.50 - EUR 358.00
52-Week Range
EUR 297.00 - EUR 389.50
Previous Close
EUR 357.50
Volume
N/A
Average Volume (3M)
5,164
Market Cap
EUR 2.99B
Enterprise Value
EUR 2.98B
Total Cash (Recent Filing)
EUR 171.05M
Total Debt (Recent Filing)
EUR 359.51M
Price to Earnings (P/E)
19.3
Beta
0.59
Next Earnings
Mar 23, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jul 02, 2026
Dividend Yield
0.41%

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Profitability

Accelerating revenue and consistently solid profitability indicate durable demand for Virbac’s animal-health portfolio. Stable margins provide earnings resilience and support continued investment in product development, commercial expansion, and manufacturing capabilities over the coming quarters.

Conservative Balance Sheet

Low-to-moderate leverage and an expanding equity base give Virbac financial flexibility to fund operations and strategic investment. Strong mid-teens returns on equity also indicate that the company is generating attractive earnings from its capital base.

Diversified Animal-Health Platform

A broad product portfolio serving both companion animals and livestock diversifies Virbac’s revenue base across therapies, prevention, care, and diagnostics. Its international reach and veterinary-channel presence can support recurring demand and reduce reliance on any single product or market.

Bears Say

Moderate Cash Conversion

Healthy reported profits are not converting fully into free cash flow, creating potential variability in internally generated funding. Moderate conversion may reflect working-capital or investment needs, limiting the cash available for debt reduction, reinvestment, or shareholder returns.

Margin Variability

Although profitability remains solid, the lack of margin expansion and history of gross-margin volatility suggest that earnings quality may be sensitive to changes in cost mix or operating conditions. Sustained revenue growth therefore may not translate proportionally into profit growth.

Reduced Balance-Sheet Flexibility

The increase in leverage is not currently excessive, but it reduces the financial cushion that Virbac previously enjoyed. Higher debt relative to equity can constrain flexibility for acquisitions, investment, or downturn management if operating conditions weaken over the next several quarters.

Virbac SA News

VIRP FAQ

What was Virbac SA’s price range in the past 12 months?
Virbac SA lowest stock price was €297.00 and its highest was €389.50 in the past 12 months.
What is Virbac SA’s market cap?
Virbac SA’s market cap is €2.99B.
When is Virbac SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Virbac SA’s earnings last quarter?
Virbac SA released its earnings results on Sep 17, 2026. The company reported €10.428 earnings per share for the quarter.
Is Virbac SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Virbac SA pay dividends?
Virbac SA pays an annual dividend of €1.45 which represents an annual dividend yield of 0.41%. See more information on Virbac SA dividends here
What is Virbac SA’s EPS estimate?
Virbac SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virbac SA have?
Virbac SA has 8,390,660 shares outstanding.
What happened to Virbac SA’s price movement after its last earnings report?
Virbac SA reported an EPS of €10.428 in its last earnings report. Following the earnings report the stock price went up 0.801%.
Which hedge fund is a major shareholder of Virbac SA?
Currently, no hedge funds are holding shares in FR:VIRP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology